NO20020516L - Stabilt farmasöytisk preparat for oralt bruk - Google Patents

Stabilt farmasöytisk preparat for oralt bruk

Info

Publication number
NO20020516L
NO20020516L NO20020516A NO20020516A NO20020516L NO 20020516 L NO20020516 L NO 20020516L NO 20020516 A NO20020516 A NO 20020516A NO 20020516 A NO20020516 A NO 20020516A NO 20020516 L NO20020516 L NO 20020516L
Authority
NO
Norway
Prior art keywords
drug
present
oral use
stable pharmaceutical
pharmaceutical preparation
Prior art date
Application number
NO20020516A
Other languages
English (en)
Other versions
NO20020516D0 (no
NO331834B1 (no
Inventor
Kazuhiro Sako
Toyohiro Sawada
Keiichi Yoshihara
Tatsunobu Yoshioka
Shunsuke Watanabe
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22520720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20020516(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of NO20020516D0 publication Critical patent/NO20020516D0/no
Publication of NO20020516L publication Critical patent/NO20020516L/no
Publication of NO331834B1 publication Critical patent/NO331834B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20020516A 1999-08-04 2002-02-01 Stabilt farmasoytisk preparat for oral bruk, fremgangsmate for fremstilling derav, fremgangsmate for a hindre endringer i frigivelsesprofil for et legemiddel, og anvendelse av ferrioksid for dette. NO331834B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14722299P 1999-08-04 1999-08-04
PCT/JP2000/005075 WO2001010466A1 (fr) 1999-08-04 2000-08-01 Compositions medicinales stables pour administration orale

Publications (3)

Publication Number Publication Date
NO20020516D0 NO20020516D0 (no) 2002-02-01
NO20020516L true NO20020516L (no) 2002-02-01
NO331834B1 NO331834B1 (no) 2012-04-16

Family

ID=22520720

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020516A NO331834B1 (no) 1999-08-04 2002-02-01 Stabilt farmasoytisk preparat for oral bruk, fremgangsmate for fremstilling derav, fremgangsmate for a hindre endringer i frigivelsesprofil for et legemiddel, og anvendelse av ferrioksid for dette.

Country Status (17)

Country Link
EP (1) EP1205190B1 (no)
JP (1) JP3462490B2 (no)
KR (1) KR100507400B1 (no)
CN (1) CN1193792C (no)
AT (1) ATE324909T1 (no)
AU (1) AU769807B2 (no)
CA (1) CA2387705C (no)
DE (1) DE60027728T2 (no)
DK (1) DK1205190T3 (no)
ES (1) ES2262528T3 (no)
HU (1) HU229295B1 (no)
MX (1) MXPA02001267A (no)
NO (1) NO331834B1 (no)
PL (1) PL200645B1 (no)
PT (1) PT1205190E (no)
RU (1) RU2220715C2 (no)
WO (1) WO2001010466A1 (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003225206B2 (en) * 2002-04-24 2008-02-14 Forest Laboratories Holdings Limited Prevention and treatment of functional somatic disorders, including stress-related disorders
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
ZA200409537B (en) * 2003-01-31 2006-10-25 Yamanouchi Pharma Co Ltd Stable solid medicinal composition for oral administration
US7442387B2 (en) * 2003-03-06 2008-10-28 Astellas Pharma Inc. Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
JP2005162736A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
JP2005162737A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
US7358270B2 (en) 2004-01-30 2008-04-15 Astellas Pharma Inc. Treating agent for irritable bowel syndrome
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
JP4632204B2 (ja) * 2005-09-21 2011-02-16 アステラス製薬株式会社 下痢型過敏性腸症候群治療剤
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
WO2010084397A2 (en) * 2009-01-20 2010-07-29 Micro Labs Limited Modified release solid pharmaceutical compositions of trimetazidine and process thereof
RU2567723C2 (ru) 2009-07-22 2015-11-10 Грюненталь Гмбх Стабильная при окислении, прочная на излом лекарственная форма
BR112012001547A2 (pt) 2009-07-22 2016-03-08 Gruenenthal Gmbh forma de dosagem farmacêutica extrusada por fusão a quente
US20120070465A1 (en) 2010-03-29 2012-03-22 Astellas Pharma Inc. Pharmaceutical composition for modified release
RU2604676C2 (ru) 2010-09-02 2016-12-10 Грюненталь Гмбх Устойчивая к разрушению лекарственная форма, содержащая неорганическую соль
KR102027912B1 (ko) 2011-02-15 2019-10-02 지엘팜텍주식회사 경구투여용 탐술로신 또는 이의 약제학적으로 허용되는 염을 포함하는 서방성 삼중정제
CA2839123A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
DK2736497T3 (da) 2011-07-29 2017-11-13 Gruenenthal Gmbh Stød-resistent tablet, der tilvejebringer en øjeblikkelig frigivelse af et lægemiddel.
WO2013156453A1 (en) 2012-04-18 2013-10-24 Grünenthal GmbH Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
CA2907950A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
AU2014289187B2 (en) 2013-07-12 2019-07-11 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
MX371372B (es) 2013-11-26 2020-01-28 Gruenenthal Gmbh Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
EP3142646A1 (en) 2014-05-12 2017-03-22 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
JP2017516789A (ja) 2014-05-26 2017-06-22 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング エタノール過量放出に対して防護されている多粒子
JP6630344B2 (ja) * 2015-03-19 2020-01-15 第一三共株式会社 着色剤を含有する固形製剤
WO2016148263A1 (ja) 2015-03-19 2016-09-22 第一三共株式会社 抗酸化剤を含有する固形製剤
KR20170139158A (ko) 2015-04-24 2017-12-18 그뤼넨탈 게엠베하 즉시 방출되고 용매 추출 방지된 변조 방지된 투여 형태
TWI722988B (zh) 2015-06-05 2021-04-01 瑩碩生技醫藥股份有限公司 緩釋性醫藥組合物及其製備方法
CA2998259A1 (en) 2015-09-10 2017-03-16 Grunenthal Gmbh Protecting oral overdose with abuse deterrent immediate release formulations
SI3360866T1 (sl) 2017-02-14 2019-04-30 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Mirabegronska predzdravila
EP3722285B1 (en) 2020-04-08 2022-03-30 Alfred E. Tiefenbacher (GmbH & Co. KG) Process for preparing mirabegron enacarbil

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU198844B (en) * 1984-06-14 1989-12-28 Sandoz Ag Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
HU206824B (en) * 1990-08-24 1993-01-28 Biogal Gyogyszergyar Process for the production of a table crystallizing in the monoclinic system, which contains light-, heat-, and moisture- sensitive active agents
JP2820829B2 (ja) * 1991-03-07 1998-11-05 武田薬品工業株式会社 有核散剤およびその製造方法
JPH04346929A (ja) * 1991-05-22 1992-12-02 Takada Seiyaku Kk 光に安定なメシル酸ブロモクリプチン製剤
DE69619979T2 (de) * 1995-04-14 2002-11-21 Pharma Pass Illkirch Graffenst Feste zusammensetzungen mit einem nicht-amorphem wirkstoff und polyäthylenoxyd
WO1999006045A1 (en) * 1997-08-01 1999-02-11 Elan Corporation, Plc Controlled release pharmaceutical compositions containing tiagabine
EP0901787B1 (en) * 1997-09-10 2003-05-28 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition

Also Published As

Publication number Publication date
AU769807B2 (en) 2004-02-05
RU2220715C2 (ru) 2004-01-10
DE60027728D1 (de) 2006-06-08
CN1373673A (zh) 2002-10-09
EP1205190B1 (en) 2006-05-03
CA2387705C (en) 2009-06-30
EP1205190A4 (en) 2004-01-21
AU6182100A (en) 2001-03-05
CA2387705A1 (en) 2001-02-15
HU229295B1 (en) 2013-10-28
HUP0202495A3 (en) 2004-05-28
MXPA02001267A (es) 2002-08-12
EP1205190A1 (en) 2002-05-15
DK1205190T3 (da) 2006-08-14
DE60027728T2 (de) 2007-04-26
ES2262528T3 (es) 2006-12-01
HUP0202495A2 (hu) 2002-11-28
NO20020516D0 (no) 2002-02-01
PT1205190E (pt) 2006-09-29
PL353154A1 (en) 2003-10-20
WO2001010466A1 (fr) 2001-02-15
KR20020046277A (ko) 2002-06-20
ATE324909T1 (de) 2006-06-15
CN1193792C (zh) 2005-03-23
KR100507400B1 (ko) 2005-08-10
JP3462490B2 (ja) 2003-11-05
PL200645B1 (pl) 2009-01-30
NO331834B1 (no) 2012-04-16

Similar Documents

Publication Publication Date Title
NO20020516D0 (no) Stabilt farmasöytisk preparat for oralt bruk
RU2002102701A (ru) Стабильная пероральная образующая гидрогель, фармацевтическая композиция, способ ее получения, способ предотвращения изменений высвобождения лекарственного средства, способ увеличения физической стабильности пероральной композиции
DE69622510T2 (de) Nifedipinzubereitung mit langanhaltender Freisetzung
ATE324104T1 (de) Mesalazine enthaltende pharmazeutische zusammensetzungen mit gesteuerter freisetzung
NO20020180D0 (no) Nye kinuklidinderivater og medisinske sammensetninger inneholdende det samme
DE69309540D1 (de) Orale Arzneimittel mit kolonspezifischer Freisetzung
DE69201956T2 (de) Pyrrolidin- und thiazolidinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE60042972D1 (de) Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
PT1138333E (pt) Composicao farmaceutica oral
ATE371441T1 (de) Verfahren zur herstellung einer pharmazeutischen zubereitung mit 5-aminosalicylsäure zur verwendung bei der behandlung von colitis ulcerosa und morbus crohn
DE69723024D1 (de) Pharmazeutische Zusammensetzungen mit kontrollierter Freisetzung zur oralen Verabreichung enthaltend Nifedipin als Wirkstoff
DE69406853T2 (de) Alpha Aminosäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
SE9902935D0 (sv) Pharmaceutical compositions
DE3688397T2 (de) 3-(2-aminoethyl)indol und -indolinderivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
ATE125538T1 (de) Thiochromanderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DE69209916D1 (de) Oral anzuwendende Arzneimittel Dapiprazol enthaltend
ITMI911845A1 (it) Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.
ATE121297T1 (de) Neue polycarbophil enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung.
PL1603559T3 (pl) Kompozycja farmaceutyczna do wewnątrzkomórkowego zakwaszania kwasem cis-urokanowym
ATA52288A (de) Malonsaeurederivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzung, enthaltend diese verbindungen

Legal Events

Date Code Title Description
MK1K Patent expired